BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2021
View Archived Issues
OTO-313 well tolerated and promising for treating tinnitus
Read More
Treatment with Escozine results in apoptosis of various types of leukemia cancer cell lines
Read More
Repare Therapeutics provides updates regarding its RP-6306 program
Read More
Context Therapeutics and Integral Molecular collaborate to develop novel anti-CLDN6 antibodies
Read More
Mersana initiates UPLIFT registration strategy for upifitamab rilsodotin
Read More
AACR 2021: Research points to ways to fight cachexia's bite
Read More
Pinteon Therapeutics initiates phase I study of PNT-001 in traumatic brain injury
Read More
Enrollment ongoing in phase I study of tomivosertib plus paclitaxel in advanced breast cancer
Read More
Takeda Pharmaceutical patents GPR139 agonists
Read More
Novartis AG discloses new PROTACs
Read More
Albert-Ludwigs-Universitat Freiburg synthesizes N6AMT1 inhibitors
Read More
BIAL - Biotech Investments presents new ASAH1 inhibitors
Read More
Moderna initiates phase I study of its COVID-19 variant vaccine mRNA-1273.351
Read More
Genentech and Roche discover new KLK7-targeting antibodies
Read More
Phase III study of casirivimab + imdevimab to prevent symptomatic COVID-19 infection meets endpoints
Read More
Pooled data from the AURORA and AURA-LV trials across lupus nephritis biopsy classes
Read More
Antengene initiates phase II study of ATG-008 in advanced solid tumors with genetic alterations
Read More
SEMA7A is a prognostic factor in ER+ breast cancer
Read More
Data from ongoing phase Ib/II study of onvansertib in second-line metastatic colorectal cancer
Read More
New phase III study assesses contraceptive efficacy of relugolix combination tablet
Read More
